Podcast
Questions and Answers
What percentage of patients with adult-acquired hepatitis B infection are at risk of developing chronicity?
What percentage of patients with adult-acquired hepatitis B infection are at risk of developing chronicity?
In chronic HBV infection, which symptom is most frequently reported?
In chronic HBV infection, which symptom is most frequently reported?
Which condition is characterized by severe cholestatic jaundice and deterioration of graft functions in liver transplant recipients?
Which condition is characterized by severe cholestatic jaundice and deterioration of graft functions in liver transplant recipients?
What is the defining criterion for chronic HBV infection diagnosis?
What is the defining criterion for chronic HBV infection diagnosis?
Signup and view all the answers
Which of the following extrahepatic manifestations is associated with chronic hepatitis B infection?
Which of the following extrahepatic manifestations is associated with chronic hepatitis B infection?
Signup and view all the answers
What percentage of patients with chronic hepatitis B may experience symptoms?
What percentage of patients with chronic hepatitis B may experience symptoms?
Signup and view all the answers
Which of the following is NOT a common symptom of chronic hepatitis B infection?
Which of the following is NOT a common symptom of chronic hepatitis B infection?
Signup and view all the answers
What is a rare but severe form of liver injury associated with HBV reactivation in immunosuppressed patients?
What is a rare but severe form of liver injury associated with HBV reactivation in immunosuppressed patients?
Signup and view all the answers
What does the presence of HBsAg in serum initially indicate in relation to hepatitis B?
What does the presence of HBsAg in serum initially indicate in relation to hepatitis B?
Signup and view all the answers
Which marker signifies diminished viral replication and decreased infectivity in hepatitis B infections?
Which marker signifies diminished viral replication and decreased infectivity in hepatitis B infections?
Signup and view all the answers
What is the significance of the quantitative HBsAg (qHBsAg) level in hepatitis B treatment?
What is the significance of the quantitative HBsAg (qHBsAg) level in hepatitis B treatment?
Signup and view all the answers
How long after acute illness does HBsAg commonly persist in chronic hepatitis B infection?
How long after acute illness does HBsAg commonly persist in chronic hepatitis B infection?
Signup and view all the answers
Which phase of chronic hepatitis B infection is associated with the presence of HBeAg?
Which phase of chronic hepatitis B infection is associated with the presence of HBeAg?
Signup and view all the answers
What is the typical recovery time for acute hepatitis B in most adults?
What is the typical recovery time for acute hepatitis B in most adults?
Signup and view all the answers
Which test result indicates a diagnosis of acute hepatitis B during the window period?
Which test result indicates a diagnosis of acute hepatitis B during the window period?
Signup and view all the answers
What percentage of patients with chronic hepatitis B may develop cirrhosis?
What percentage of patients with chronic hepatitis B may develop cirrhosis?
Signup and view all the answers
Who should receive screening for HBV infection?
Who should receive screening for HBV infection?
Signup and view all the answers
What characteristic defines a protective immune response from the HBV vaccine?
What characteristic defines a protective immune response from the HBV vaccine?
Signup and view all the answers
What should be done for unvaccinated persons after exposure to HBsAg-contaminated material?
What should be done for unvaccinated persons after exposure to HBsAg-contaminated material?
Signup and view all the answers
What is the optimal goal of therapy for chronic hepatitis B?
What is the optimal goal of therapy for chronic hepatitis B?
Signup and view all the answers
In which patients is post-vaccination anti-HBs titer testing necessary?
In which patients is post-vaccination anti-HBs titer testing necessary?
Signup and view all the answers
What is the recommended site for the administration of the HBV vaccine for best absorption?
What is the recommended site for the administration of the HBV vaccine for best absorption?
Signup and view all the answers
Which group is most likely to exhibit low vaccination response rates to HBV vaccine?
Which group is most likely to exhibit low vaccination response rates to HBV vaccine?
Signup and view all the answers
What measure is unnecessary for patients infected with HBV who are under treatment?
What measure is unnecessary for patients infected with HBV who are under treatment?
Signup and view all the answers
What is a common side effect associated with telbivudine treatment?
What is a common side effect associated with telbivudine treatment?
Signup and view all the answers
In which scenario can NUCs be discontinued?
In which scenario can NUCs be discontinued?
Signup and view all the answers
What is the typical dosing schedule for pegylated interferon alpha (PEG-IFNα)?
What is the typical dosing schedule for pegylated interferon alpha (PEG-IFNα)?
Signup and view all the answers
What is one of the contraindications for pegylated interferon alpha treatment?
What is one of the contraindications for pegylated interferon alpha treatment?
Signup and view all the answers
What percentage of patients treated with PEG-IFNα may maintain virological response after drug withdrawal?
What percentage of patients treated with PEG-IFNα may maintain virological response after drug withdrawal?
Signup and view all the answers
What is a potential adverse effect of PEG-IFNα treatment?
What is a potential adverse effect of PEG-IFNα treatment?
Signup and view all the answers
What is the reported rate of HBsAg seroclearance after a 3-year post-treatment follow-up of PEG-IFNα?
What is the reported rate of HBsAg seroclearance after a 3-year post-treatment follow-up of PEG-IFNα?
Signup and view all the answers
Which patient demographic is pegylated interferon alpha particularly recommended for?
Which patient demographic is pegylated interferon alpha particularly recommended for?
Signup and view all the answers
What is the primary goal of antiviral therapy for HBV?
What is the primary goal of antiviral therapy for HBV?
Signup and view all the answers
Which type of antiviral therapy is preferred for patients with decompensated cirrhosis?
Which type of antiviral therapy is preferred for patients with decompensated cirrhosis?
Signup and view all the answers
Which of the following NUCs has been noted to cause lactic acidosis in patients with decompensated cirrhosis?
Which of the following NUCs has been noted to cause lactic acidosis in patients with decompensated cirrhosis?
Signup and view all the answers
Which of the following NUCs is least potent for treating HBV?
Which of the following NUCs is least potent for treating HBV?
Signup and view all the answers
What is a significant concern associated with long-term use of Tenofovir disoproxil fumarate?
What is a significant concern associated with long-term use of Tenofovir disoproxil fumarate?
Signup and view all the answers
Which NUC therapy is associated with the lowest rates of HBsAg seroclearance?
Which NUC therapy is associated with the lowest rates of HBsAg seroclearance?
Signup and view all the answers
What is a critical consideration when switching therapy for patients with HBV resistance?
What is a critical consideration when switching therapy for patients with HBV resistance?
Signup and view all the answers
What is the desired endpoint for HBeAg-positive patients receiving antiviral therapy for HBV?
What is the desired endpoint for HBeAg-positive patients receiving antiviral therapy for HBV?
Signup and view all the answers
Study Notes
Acute Hepatitis B
- Clinical manifestations range from asymptomatic to icteric hepatitis; may rarely lead to fulminant hepatitis.
- Acute illness typically resolves within 2-3 weeks; full clinical recovery by 16 weeks.
- Perinatal or childhood infections have high chronicity (90%); adult infections exhibit low chronicity rates (1-5%).
- Immunocompromised patients are at higher risk for chronic HBV infection.
Chronic Hepatitis B
- Chronic HBV infection is diagnosed when HBsAg and high HBV DNA persist for over 6 months.
- Symptoms include fatigue; physical exams reveal signs of chronic liver disease.
- 10-30% of patients with chronic hepatitis B may exhibit symptoms.
- Serious complications include cirrhosis and hepatocellular carcinoma (HCC).
- Acute disease flares can mimic acute hepatitis.
Diagnosis and Serological Markers
- Elevated serum aminotransferase levels characterize acute hepatitis B; marked cholestasis is not present.
- Key serological markers include:
- HBsAg: First indicator of acute infection; becomes undetectable in recovering patients.
- Anti-HBs: Signifies recovery and non-infectivity; may show a "window period" before detection.
- Anti-HBc IgM: Indicates active acute hepatitis B; appears shortly after HBsAg.
- Anti-HBc IgG: Indicates recovery; appears with anti-HBs.
- HBeAg: Indicates HBV replication; appears shortly after HBsAg.
- Anti-HBe: Signals diminished viral replication; appears after HBeAg.
Prognosis and Statistics
- Acute hepatitis B resolves in 90-95% of adults within 3-6 months.
- Acute liver failure occurs in <1% of cases with high mortality (up to 60%).
- Risk of cirrhosis in chronic HBV is 40%; higher in co-infected patients (HCV/HIV).
- Annual HCC risk in cirrhosis patients is 3-5%.
Prevention Strategies
- Regular screening for high-risk groups and all pregnant women for HBsAg is essential.
- Blood donation screening significantly reduces transfusion-related hepatitis risk.
- Universal vaccination programs have shown promising results in endemic areas.
Immunoprophylaxis
- HBV Vaccine: Recommended for infants, children, and high-risk adults. Safe in pregnancy, with various formulations available.
- Hepatitis B Immune Globulin (HBIG): Provides post-exposure prophylaxis if given within 7 days after exposure. Critical for newborns from HBsAg-positive mothers.
Treatment of Hepatitis B
- Acute Hepatitis B: Primarily supportive; may require antiviral treatment in severe cases.
-
Chronic Hepatitis B:
- No complete cure; aim for "functional cure" (loss of HBsAg and HBV DNA).
- Two primary antiviral therapy types: Nucleoside and Nucleotide analogs (NUCs) and Pegylated Interferon Alpha (PEG-IFNα).
Antiviral Therapy
-
Nucleoside and Nucleotide Analogs (NUCs):
- Include lamivudine, entecavir, adefovir, TDF, and TAF.
- High barrier to resistance; long-term therapy required.
- Entecavir and TDF are first-line treatments; TAF has less renal toxicity.
-
Pegylated Interferon Alpha (PEG-IFNα):
- Alternative to NUCs with both antiviral and immunomodulatory effects.
- Limited course; potential for sustained response post-treatment.
- Common side effects include flu-like symptoms and myelosuppression.
Monitoring and Follow-Up
- Monitoring for HBsAg loss and virial suppression is crucial after antiviral therapy.
- Close follow-up is necessary for patients at high risk of reactivation following NUC discontinuation.
Studying That Suits You
Use AI to generate personalized quizzes and flashcards to suit your learning preferences.
Description
This quiz delves into the clinical manifestations of acute hepatitis B, covering asymptomatic, icteric, and fulminant cases. It examines the recovery timeline and contrasts perinatal versus adult-acquired infections. Test your understanding of this important viral infection's characteristics and outcomes.
